Navigation Links
LeMaitre Vascular Announces Changes to Its Executive Management Team
Date:4/10/2008

executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803.

Certain statements set forth above that are not clearly historical in nature are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the company believes that such statements are based on reasonable assumptions within the bounds of its knowledge, these forward-looking statements are neither promises nor guarantees. The forward-looking statements made in this release are made only as of the date hereof, and the company disclaims any intention or responsibility for updating predictions or expectations contained in this release.


'/>"/>
SOURCE LeMaitre Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. LeMaitre Vascular to Start Italian Sales Force
2. LeMaitre Vascular to Participate at CIBC 18th Annual Healthcare Conference
3. LeMaitre Vascular Reports Q3 2007 Revenue of $10.1 Million, a 19% Increase
4. LeMaitre Vascular to Participate at Canaccord Adams Inaugural Cardiovascular Conference
5. LeMaitre Vascular Launches Next-Generation Stent Graft Delivery System
6. LeMaitre Vascular, Inc. Schedules Fourth Quarter Results and Conference Call
7. LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
8. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
9. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
10. Pot bellies linked to early signs of cardiovascular disease
11. Air pollution linked to cardiovascular risk indices in healthy young adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Boston, MA (PRWEB) Decembe... not be as funny as David Letterman,s nightly coun... long-term health. Here are this year,s winners, c... Letter:, , , , ,1. Blood sugar: How low should i...ugar levels is probably not the best approach to t...
(Date:12/4/2008)...s for PE Classrooms Released , , CORPUS CHR...hundreds of physical educators at the annual Texas...e (TAHPERD) conference, Source Brands, Inc., maker...ly released the first "active gaming" lesson plans... is entitled GameCoach(TM) and is available nati...
(Date:12/4/2008)...ication used for high blood pressure does not impr...ew results from a large, international study. , ...est University Baptist Medical Center in key leade...he New England Journal of Medicine , published to...hers, who continue to study other medications in s...
(Date:12/4/2008)...wswire/ -- The American Academy of,Dermatology (A...tamin D,drawing on the scientific literature to ...n adequate amount of this vitamin. The Academy re...tritional sources and dietary supplements, and,no...diation from the sun or,indoor tanning devices, a...
Breaking Medicine News(10 mins):Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 2Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 3Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 4Health News:GameCoach(TM) Combines High Tech With Old School PE School Equipment 2Health News:Study finds treatment fails to improve common form of heart failure 2Health News:Study finds treatment fails to improve common form of heart failure 3Health News:American Academy of Dermatology Issues Position Statement on Vitamin D 2
...udy has revealed that a surveillance programme des...is units could cut the number of infections among ...hers from Imperial College London and Hammersmith ...British Medical Journal, shows how the implementat...
...protect against heart disease, cancer and eye prob... that eggs were bad for cholesterol levels. // Br...0 egg studies and found that people who consumed o...risk of suffering from cardiovascular disease than...
...he study done by Roseborough et al., mitochondrial...a-reperfusion injury in the rabbit spinal cord. //... during aortic surgery but surgery done to repair ...ficits. But the works of Roseborough et al has giv...
... by researchers from Duke University Medical Cente...blood transfusion into patient //who has undergone...e with raised death risks. Use of older blood als...or kidney problems,acute respiratory distress and ...
Other Medicine News:Health News:Surveillance Program for Haemodialysis Reduces Infection 2Health News:Consumption of an Egg per day Could Prevent Heart Disease, Cancer 2Health News:New Way To Combat Spinal Cord Injury during Aortic Surgery 2Health News:Repeated Heart Surgery with Older Blood Transfusion Pack More Death Risk 2Health News:Repeated Heart Surgery with Older Blood Transfusion Pack More Death Risk 3
(Date:12/4/2008)...December 4 Biopharmaceutical compa...essfully completed treatment of the,last patient ...), a donor,lymphocyte cell based product, is unde...Disease (GvHD) and allow early immune reconstituti...tion. Nineteen end stage blood cancer,patients we...
(Date:12/4/2008)...tive TLR8 Agonist to Advance to Clinical Trials ,... Pharmaceuticals, Inc., a biopharmaceutical compan...ceptor 8 (TLR8) agonists for the treatment of canc... today that it has initiated a Phase I clinical tr...treatment of cancer. The multi-center clinical tr...
(Date:12/4/2008)...Dec. 4 NovaRx Corporation announce....D to the position of President and Chief Operatin... than 25 years experience in drug discovery and a ...maceutical discovery and development. He also has...companies developing pioneering new technologies. ...
(Date:12/4/2008)...lif.,Dec. 4 Velos, Inc., the recog...als management information systems, today announce...sity of Kansas Medical Center (KU Medical Center)... a comprehensive, system-wide roll-out that suppor...linical information needs of the institution,s cli...
Breaking Medicine Technology:Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3University of Kansas Medical Center to Deploy Velos eResearch System-Wide 2University of Kansas Medical Center to Deploy Velos eResearch System-Wide 3Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 1Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 2Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 3Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 1Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 2Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 3Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 4UD researchers discover novel gene toggles in worlds top food crop 2835 1UD researchers discover novel gene toggles in worlds top food crop 2835 2UD researchers discover novel gene toggles in worlds top food crop 2835 3Stenting as Good as Surgery for Stroke Prevention 16422 1Stenting as Good as Surgery for Stroke Prevention 16422 2
...ortly, CARMIEL, Israel, April 18, 2007 /PRNewswire...ay announced that it has received,written notice f...,(FDA) that it may initiate a Phase III clinical t...idate, prGCD, a proprietary plant,cell expressed r...,for the treatment of Gaucher Disease, a lysosomal...
...eting Also Showed No,Significant Impact on Weight ...ay 21, 2007 /PRNewswire-FirstCall/ --,Findings fro...,effect of desvenlafaxine succinate on anxious sym... with major depressive disorder,(MDD) -- as well a...ect of desvenlafaxine succinate on weight change i...
Other Medicine Technology:Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: